Sumit Mukesh

Sumit Mukesh serves as a Research Scientist - Manager I at Lupin, where he plays a pivotal role in the development of complex injectable formulations, including suspensions, peptides, and lyophilized products. His expertise lies in solid-state pharmaceutics, particularly in enhancing solubility, dissolution, and bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs). With a strong foundation in the development and characterization of Amorphous Solid Dispersions (ASD), Sumit has pioneered innovative approaches such as in situ Polymeric Amorphous Salts and co-crystals, which significantly improve the therapeutic efficacy of challenging compounds.

In his current role, Sumit leads key projects that focus on the formulation development of complex injectables, ensuring that they meet stringent regulatory standards while also addressing the unique challenges posed by each API. His proficiency in solid-state characterization techniques allows him to analyze APIs, excipients, and formulations meticulously, utilizing various analytical methods such as HPLC and advanced solid-state characterization techniques. This expertise is complemented by his adeptness in scientific data retrieval from multiple search engines and patent databases, enabling him to stay at the forefront of pharmaceutical research and innovation.

Sumit's contributions extend beyond formulation development; he is also deeply involved in preformulation studies and regulatory affairs, ensuring that all products not only meet scientific and quality benchmarks but also comply with industry regulations. His commitment to advancing pharmaceutical science is evident in his collaborative efforts within multidisciplinary teams, driving projects from conception through to successful execution. As a leader in his field, Sumit Mukesh continues to push the boundaries of injectable formulation development, making significant strides in improving patient outcomes through innovative drug delivery systems.